We are a leading Contract Development and Manufacturing Organization (CDMO) specialized in the process development and GMP manufacturing of biopharmaceuticals and cell therapy products.
With the unique goal of making your project a success, we offer personalized services for process development and GMP manufacturing of biopharmaceutical products using Microbial and Mammalian expression systems.
Download our current GMP certification.
Keensight Capital, one of the leading European Growth Buyout firms, is committed to supporting entrepreneurs as they implement their growth strategies. For 20 years, Keensight Capital’s team of seasoned professionals has leveraged their knowledge of investment and growth industries to invest for the long term in profitable companies with high growth potential and revenues in the range of €15 million to €250 million.
Drawing on its expertise in the Information Technology/Internet and Healthcare/Wellbeing sectors, Keensight identifies the best investment opportunities in Europe and works closely with management teams to develop and achieve their strategic vision.